By leveraging AI, Hello Pearl enables dental practitioners to detect tooth decay earlier, while vVARDIS Curodont products offer a drill-free solution to treat early stages of tooth decay.
Hello Pearl, the global leader in dental AI solutions, has announced a partnership with vVARDIS, a leader in innovative dental care products, to educate dental professionals about detecting and treating early stages of dental decay. The global collaboration brings together vVARDIS, which has a biomimetic, drill-free early caries treatment product, Curodont, and Hello Pearl, which has an AI-powered real-time radiologic detection aid, Second Opinion, to deliver the message of non-invasive solutions for treating early dental decay.
Hello Pearl’s AI solutions enable dental providers to accurately detect conditions such as decay or cavities at their earliest stages, ensuring a proactive approach to oral health. Beyond early condition detection, its Second Opinion software also builds patient trust by enhancing their understanding of dental imagery, leading to higher case acceptance and more informed treatment decisions.
vVARDIS’ Curodont offers a drill-free brush-on solution to aid hydroxyapatite formation throughout the early decay, helping patients to preserve the natural tooth structure and helping to avoid invasive and costly fillings. Up to 80% of all patients have tooth decay in early stages (Skeie et al, 2022). Curodont gives dental professionals the opportunity to treat these patients with a simple and fast topical application during the same visit it’s detected, without the need for a new appointment.
‘A clinically proven solution for in-depth remineralisation of initial decay’
‘At Hello Pearl, we are dedicated to enhancing and standardising dental diagnostics by leveraging AI to simplify radiograph interpretation and improve patient communication,’ said Ophir Tanz, CEO and founder of the company. ‘Our partnership with vVARDIS enables a comprehensive, internationally scalable approach to managing dental decay – combining early, AI-driven detection with a clinically proven solution for in-depth remineralisation of initial decay – giving patients a more effective and proactive path to improved oral health.’
‘Partnering with Pearl is a natural progression in our mission to provide innovative solutions for early-stage dental decay,’ said Jeremy Thomas, president, vVARDIS north America. ‘This collaboration equips global dental professionals with modern tools to detect conditions sooner and provides a proven, non-invasive solution to restore enamel health.’
‘As both dentists and entrepreneurs, we are thrilled to finally have and offer a groundbreaking approach to treating early decay,’ said Drs Haley and Goly Abivardi, DMDs, founders and co-CEOs of vVARDIS. ’34 million of school hours are lost each year due to emergency dental care (Naavaal et al, 2018) and $45 billion in lost productivity annually from untreated oral disease (in the United States (Nasseh and Vujicic; CareQuest, 2024)).
‘Dental professionals have been waiting for decades for a drill-free treatment that addresses the sub-clinical signs of caries in the same visit. With its seamless integration into existing workflows, we believe that Curodont has the potential to rapidly become the new standard of care for the treatment of early caries, broadening the scope of services offered and empowering dentists and hygienists to lead the way in the management of early caries, ultimately enhancing patient care.’
To request a demo of Hello Pearl, please visit hellopearl.com/getdemo.
For more information about vVARDIS, visit www.vVARDIS.com or www.linkedin.com/company/vvardis.
References
- Skeie MS et al. BMC Oral Health. 2022;22:620.
- Naavaal S et al. Health Behav Policy Rev 2018;5:66-73
- Nasseh K, Vujicic M, Health Policy Institute Research Brief, American Dental Association
- CareQuest Institute for Oral Health. The Hour of Need: Productivity Time Lost Due to Urgent Oral Health Needs. Boston, MA: CareQuest Institute for Oral Health; 2024014.
This article is sponsored by Hello Pearl and vVARDIS.
